Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Michelet

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|May 1, 2009
A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patientsPierre-Marie Girard, André Cabié, Christian Michelet, et al.
HIV Clinical Trials|April 27, 2002
Salvage therapy with amprenavir and ritonavir: prospective study in 17 heavily pretreated patientsCédric Arvieux, Pierre Tattevin, Faouzi M Souala, et al.
The Journal of Infection|June 27, 2013
The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trialJean-Marc Chapplain, Eric Bellissant, Dominique Guyader, et al.
AIDS (London, England)|June 5, 2007
Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adultsDirk Schürmann, Gerd Fätkenheuer, Jacques Reynes, et al.
Antiviral Therapy|May 12, 2004
Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study)Claire Lamotte, Roland Landman, Gilles Peytavin, et al.
Arthritis Research & Therapy|July 20, 2010
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control studyMélanie Gilson, Laure Gossec, Xavier Mariette, et al.
AIDS (London, England)|September 29, 2012
Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adultsChristine Durier, Corinne Desaint, Frédéric Lucht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patientsClotilde Allavena, Virginie Ferré, Cécile Brunet-François, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Mitochondrial abnormalities in HIV-infected lipoatrophic patients treated with antiretroviral agentsJean-Marc Chapplain, Jocelyne Beillot, Jean-Marc Begue, et al.
Journal of Hepatology|May 25, 2010
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infectionPaul Calès, Philippe Halfon, Dominique Batisse, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|May 1, 2009
A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patientsPierre-Marie Girard, André Cabié, Christian Michelet, et al.
HIV Clinical Trials|April 27, 2002
Salvage therapy with amprenavir and ritonavir: prospective study in 17 heavily pretreated patientsCédric Arvieux, Pierre Tattevin, Faouzi M Souala, et al.
The Journal of Infection|June 27, 2013
The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trialJean-Marc Chapplain, Eric Bellissant, Dominique Guyader, et al.
AIDS (London, England)|June 5, 2007
Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adultsDirk Schürmann, Gerd Fätkenheuer, Jacques Reynes, et al.
Antiviral Therapy|May 12, 2004
Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study)Claire Lamotte, Roland Landman, Gilles Peytavin, et al.
Arthritis Research & Therapy|July 20, 2010
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control studyMélanie Gilson, Laure Gossec, Xavier Mariette, et al.
AIDS (London, England)|September 29, 2012
Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adultsChristine Durier, Corinne Desaint, Frédéric Lucht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patientsClotilde Allavena, Virginie Ferré, Cécile Brunet-François, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Mitochondrial abnormalities in HIV-infected lipoatrophic patients treated with antiretroviral agentsJean-Marc Chapplain, Jocelyne Beillot, Jean-Marc Begue, et al.
Journal of Hepatology|May 25, 2010
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infectionPaul Calès, Philippe Halfon, Dominique Batisse, et al.
Pageof 6